To access this element change to forms mode OFF
Grant Award View - GA288997
A novel stem cell-derived manufacturing platform for next-generation...
GA ID:
GA288997
Agency:
Department of Health and Aged Care
Approval Date:
9-Dec-2022
Publish Date:
20-Mar-2023
Category:
Medical Research
Grant Term:
1-Feb-2023 to 31-May-2025
Value (AUD):
$1,000,665.16
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DoHAC 22/23 1.1 Health Policy Research and Analysis
Grant Program:
Medical Research Future Fund
Grant Activity:
A novel stem cell-derived manufacturing platform for next-generation dendritic cell vaccines
Purpose:
Dendritic cells (DCs) are immune sentinels that alert then rid the body of 'foreign' components, including cancer. However, no clinical trials in cancer patients have ever been undertaken with the 'right' kind of DCs because not enough of them can be made. Our novel method can generate >100 times more of the 'right' kind of DCs from a patient's stem cells, In this proposal, we will adapt their generation so it meets approval for use in for a Phase I anti-cancer immunotherapy trial.
GO ID:
GO Title:
MRFF – Stem Cell Therapies Mission – 2022 Stem Cell Therapies Grant Opportunity
Internal Reference ID:
2022/MRF2024314
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
The Walter and Eliza Hall Institute of Medical Research
Recipient ABN:
12 004 251 423
Grant Recipient Location
Suburb:
Parkville
Town/City:
Parkville
Postcode:
3052
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
Country:
AUSTRALIA